Frayling TM, Beaumont RN, Jones SE, Yaghootkar H, Tuke MA, Ruth KS, Casanova F, West B, Locke J, Sharp S, Ji Y, Thompson W, Harrison J, Etheridge AS, Gallins PJ, Jima D, Wright F, Zhou Y, Innocenti F, Lindgren CM, Grarup N, Murray A, Freathy RM, Weedon MN, Tyrrell J, Wood AR
Nausea is one of the most commonly reported, especially during the initial stages of treatment
Clinical trials have shown that study participants who took Semaglutide GLP-1 once a week lost an average of 5-10% of their body weight
Theres no requirement for an in-person visit before receiving a GLP-1 prescription through telehealth, making virtual services fully accessible statewide
Nevertheless, healthcare professionals often encourage patients to be mindful of their overall beverage choices